Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Masimo — R&D Expense: $126M in FY2025, down 30.6% from a year earlier.
Where the FY2025 figure comes from
Source: Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗
Extracted from standalone SEC Form 10-Q / 10-K filings of subsidiary Masimo Corporation (CIK 0000937556) prior to the completion of its 100% merger into Danaher's Diagnostics segment on 10/06/2026 for $9.8 billion (the final standalone reporting period was FY2026Q1 ended 04/04/2026).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Masimo — R&D Expense ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 126 | -30.6% | Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 182 | +39.6% | Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 131 | – | Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗ |
Cite this data
StockData. (2026). Danaher Masimo — R&D Expense ($M), annual FY2023–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/masi-rd
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.